Reprogramming NAD+ homeostasis and FOXO3a–Nrf2 signaling mitigates bleomycin-driven pulmonary fibrosis
- DOI
- 10.1016/j.taap.2026.118045
- Published
- 2026-11
- Container
- Toxicology and Applied Pharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.taap.2026.118045,
title = {Reprogramming NAD+ homeostasis and FOXO3a–Nrf2 signaling mitigates bleomycin-driven pulmonary fibrosis},
author = {Maha Mo'men and Sameh Saber and Ahmed E. Amer and Hassan A. El-Kashef},
year = {2026},
journal = {Toxicology and Applied Pharmacology},
doi = {10.1016/j.taap.2026.118045},
url = {https://doi.org/10.1016/j.taap.2026.118045}
}RIS
TY - JOUR TI - Reprogramming NAD+ homeostasis and FOXO3a–Nrf2 signaling mitigates bleomycin-driven pulmonary fibrosis AU - Maha Mo'men AU - Sameh Saber AU - Ahmed E. Amer AU - Hassan A. El-Kashef PY - 2026 JO - Toxicology and Applied Pharmacology DO - 10.1016/j.taap.2026.118045 UR - https://doi.org/10.1016/j.taap.2026.118045 ER -
APA
Mo'men, M., Saber, S., Amer, A. E., & El-Kashef, H. A. (2026). Reprogramming NAD+ homeostasis and FOXO3a–Nrf2 signaling mitigates bleomycin-driven pulmonary fibrosis. Toxicology and Applied Pharmacology. https://doi.org/10.1016/j.taap.2026.118045
Source records
- crossref · retrieved 2026-09-25T19:58:51.628Z